The European Cancer Congress 2015

login
My congress planner
close
Forgot password

Create account

Searchable Programme for ECC2015

Keyword / Author:
  • 26
    SAT
    07:45 – 08:30
    Head and Neck

    Teaching Lecture: Dose Escalation or De-Escalation in Head and Neck Cancer?

    Chair: D. Zips (Germany)

    Speaker: V. Gregoire (Belgium)
    Display Presentation Details

  • 26
    SAT
    10:30 – 12:50
    Abstract nr
    Head and Neck

    Proffered Paper Session: Head and Neck Cancer

    Chair: V. Gregoire (Belgium)

    Chair: U. Keilholz (Germany)

    10:30
    2800
    Cabazitaxel in patients with refractory recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Final results of phase II trial UNICANCER ORL03
    Speaker: J. Fayette (France)
    Display abstract

    10:45
    2801
    Antitumor activity and safety of pembrolizumab in patients with PD-L1-positive nasopharyngeal carcinoma: Interim results from a phase 1b study
    Speaker: C. Hsu (Taiwan)
    Display abstract

    11:00
    2802
    Phase II study of first-line paclitaxel (PTX) with panitumumab (P) in patients with metastatic or recurrent head and neck cancer: TTCC-2009-03 study
    Speaker: J.C.A. Adansa Klain (Spain)
    Display abstract

    11:15
    Discussant : U. Keilholz (Germany)

    11:25
    2803
    Carbon ion radiotherapy for locally advanced parotid gland carcinomas
    Speaker: M. Koto (Japan)
    Display abstract

    11:40
    2804
    Primary surgery for advanced oropharyngeal and hypopharyngeal cancers: A nationwide study in Taiwan
    Speaker: C.T. Cheng (Taiwan)
    Display abstract

    11:55
    2805
    Overall survival gain with lenvatinib vs. placebo in radioactive iodine refractory differentiated thyroid cancer (RR-DTC): An updated analysis
    Speaker: L. Wirth (USA)
    Display abstract

    12:10
    Discussant : V. Gregoire (Belgium)

    12:20
    10LBA
    LATE BREAKING ABSTRACT: Final results of the prospective DDFMISO-trial validating hypoxia-specific PET imaging during radiochemotherapy for local control of locally advanced head-and-neck cancer
    Speaker: M. Baumann (Germany)
    Display abstract

    12:30
    11LBA
    LATE BREAKING ABSTRACT: Differences in the quality of life (QoL) and functional outcomes of treatment between HPV associated (HPV+) and HPV- patients receiving primary chemoradiotherapy in PET-NECK – a multi-centre randomized phase III controlled trial (RCT) comparing PETCT guided active surveillance with planned neck dissection (ND) for locally advanced (N2/N3) nodal metastases (LANM) in patients with head and neck squamous cell cancer (HNC) treated with primary radical chemoradiotherapy (CRT)
    Speaker: H. Mehanna (United Kingdom)
    Display abstract

    12:40
    Discussant : S. Oosting (Netherlands)

  • 26
    SAT
    15:15 – 16:15
    Head and Neck

    Debate: This House Believes that Concurrent Chemotherapy Combined with Hyperfractionated Radiotherapy Should Be the Current Standard in HPV Negative Locally Advanced Head and Neck Cancer

    Moderator: A. Psyrri (Greece)

    15:15
    Speaker in favour: P. Blanchard (France)

    15:30
    Speaker against: J.G. Eriksen (Denmark)

    15:45
    Seconder in favour: W. Budach (Germany)

    15:55
    Seconder against: M. Merlano (Italy)

    Discussion & Voting

  • 26
    SAT
    16:45 – 18:15
    Head and Neck

    Scientific Symposium: Emerging Developments and Treatment Strategies in HPV Positive Head and Neck Cancer

    Chair: L. Licitra (Italy)

    Co-Chair: U. Keilholz (Germany)
    Display Presentation Details

    16:45
    Genomic landscape of HPV related head and neck cancer
    Speaker: C.H. Chung (USA)
    Display Presentation Details

    17:05
    HPV targeted therapies in HPV associated oropharynx cancer
    Speaker: A. Psyrri (Greece)
    Display Presentation Details

    17:25
    EGFR targeted approaches in HPV related head and neck cancer: Is there any role?
    Speaker: L. Licitra (Italy)
    Display Presentation Details

    17:45
    Deintensification strategies in HPV positive oropharynx tumours
    Speaker: P. Lassen (Denmark)
    Display Presentation Details

    Discussion & Roundup

  • 27
    SUN
    11:30 – 12:30
    Head and Neck

    Special Session: Strategies to Change the Therapeutic Landscape of Head and Neck Cancer

    Chair: J.P. Machiels (Belgium)

    11:30
    Consequences of new imaging techniques in treatment of the neck
    Speaker: V. Gregoire (Belgium)

    11:40
    The future role of robotic surgery in head and neck cancer
    Speaker: R.L. Ferris (USA)
    Display Presentation Details

    11:50
    Novel compounds, trial designs and imaging modalities
    Speaker: J.P. Machiels (Belgium)
    Display Presentation Details

    Discussion

Print all results list